United States · 
Who invested in Enlaza Therapeutics?
Enlaza Therapeutics's investors include Lightspeed Venture Partners and Samsara BioCapital.
United States · Venture startup
Who invested in Enlaza Therapeutics
Funding summaryUpdated 26 Oct 2026
$15Mraised across 1 round since 2025, from 1 source
- Latest round
- Venture, $15MSept 2025
- Investors
- 2
The rounds
- Sept 2025Venture$15M
Source recordedSEC filing: $15M sold, first sale Aug 2025
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Enlaza Therapeutics
How much has Enlaza Therapeutics raised?
Enlaza Therapeutics has raised $15M across 1 round since 2025.
When did Enlaza Therapeutics last raise?
Enlaza Therapeutics's most recent round was a Venture of $15M in Sept 2025.
What was Enlaza Therapeutics's biggest round?
Its most recent round, $15M in Sept 2025, is also its largest on record.
Who backed Enlaza Therapeutics first?
Enlaza Therapeutics's first round on record, in Sept 2025, was backed by Lightspeed Venture Partners and Samsara BioCapital.
What stage is Enlaza Therapeutics at?
Enlaza Therapeutics's latest named round is a Venture, in Sept 2025.
Where is Enlaza Therapeutics based?
Enlaza Therapeutics is based in the United States.
Companies like Enlaza Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.